Primary: Describe the efficacy of 0.25% and 0.5% topical timolol maleate Gel-forming solution (GFS) as assessed through Infantile Hemangioma (IH) changes in volume.~Secondary: Describe the safety of topical timolol maleate GFS for treatment of IH.
The purpose of this study is to assess the safety and efficacy of Timolol 0.25% and 0.5% doses.